Product Manager, Mutation & Variant Content (4088)

Job Location
Waltham, MA
Job Description

The Product Manager will lead the product management function for QIAGEN’s line of mutation and variant content products. The Product Manager will work closely with key opinion leaders and customers as well as internal experts and stakeholders to define, build, and drive growth of the products within the mutation and variant content portfolio.


• Define content acquisition requirements from available sources including public and private databases as well as literature curation.
• Develop the product roadmap and release plan for the products within the mutation and variant content portfolio. Prioritize development activities, monitor and resolve conflicts that arise within the portfolio as well as across other content portfolios.
• Work closely with marketing, customer and scientific support and sales to define market strategy and pricing, promote awareness and adoption of products by the market and to drive product sales.
• Present and discuss QIAGEN’s content initiatives and product offerings in conferences, webinars, user groups, blogs and other forums.

• Ph.D. in the life sciences with a genetics, genomics or medical background. Bioinformatics or medical informatics experience is a plus, particularly in the areas of human variant analysis or pharmacogenomics.
• Familiarity with ontologies, especially biomedical ontologies (MeSH, HPO, SNOMED), as well as familiarity with commonly used public mutation and variant databases (dbSNP, HGMD, PharmGKB, ClinVar).
• Informatics or related product management experience.
• Excellent oral and written communication skills.
• Comfortable working independently in a distributed, international environment.
• Outgoing personality, team player with strong business acumen. Aptitude and desire to work with both technical and non-technical personnel to build competitive, scientifically sound products.

How to Apply

If interested, please apply online

About Our Organization

QIAGEN N.V., a Netherlands-based holding company, is the leading global provider of Sample to Insight solutions to transform biological materials into valuable molecular insights. QIAGEN sample technologies isolate and process DNA, RNA and proteins from blood, tissue and other materials. Assay technologies make these biomolecules visible and ready for analysis. Bioinformatics software and knowledge bases interpret data to report relevant, actionable insights. Automation solutions tie these together in seamless and cost-effective molecular testing workflows. QIAGEN provides these workflows to more than 500,000 customers around the world in Molecular Diagnostics (human healthcare), Applied Testing (forensics, veterinary testing and food safety), Pharma (pharmaceutical and biotechnology companies) and Academia (life sciences research). As of March 31, 2015, QIAGEN employed approximately 4,300 people in over 35 locations worldwide. Further information can be found at

At Nature, Johns Hopkins' Gundula Bosch describes her graduate program that aims to get doctoral students thinking about the big picture.

Patricia Fara writes about childcare funding, and women in science and science history at NPR.

National Institute of Environmental Health Sciences researchers have visualized the career paths of former postdocs.

A new survey from the Pew Research Center finds that half of women working in STEM have experienced gender discrimination at work.